Thanks @TomYoung for reviewing! In our case, it being a Swiss company I guess it's termed a little different. The strike price (that's how it's labelled in all the documents) on the SSARs is the FMV at the time of Grant.
But, conceptually, sounds like we are aligned. The SSARs are valued based on the increase in the FMV between grant and exercise. This increase in FMV is reported and taxed via the W2. Then the "cost basis" we report in the 1099-B is the FMV at exercise (not grant), to ensure we are not double taxed.
